Search research articles
Contact Us
Filters
Showing results (61-70 of 289) with videos related to
Page
of 29
Sort By:
Expert Review of Anticancer Therapy
|
December 15, 2015
Treatment of elderly patients with metastatic renal cell carcinoma
Elisa Zanardi, Paolo Grassi, Alessia Cavo, et al.
Therapeutic Advances in Urology
|
July 11, 2015
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma
Elisa Zanardi, Elena Verzoni, Paolo Grassi, et al.
American Journal of Clinical Oncology
|
September 26, 2013
Safety of Abiraterone Acetate in Castration-resistant Prostate Cancer Patients With Concomitant Cardiovascular Risk Factors
Giuseppe Procopio, Paolo Grassi, Isabella Testa, et al.
Clinical Genitourinary Cancer
|
August 28, 2014
Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data
Roberto Iacovelli, Matteo Santoni, Elena Verzoni, et al.
Cancer Biology & Therapy
|
July 25, 2012
Medical strategies for treatment of castration resistant prostate cancer (CRPC) docetaxel resistant
Amelia Altavilla, Roberto Iacovelli, Giuseppe Procopio, et al.
Tumori
|
August 8, 2007
Merkel cell carcinoma after liver transplantation: a case report
Emilio Bajetta, Marco Platania, Laura Catena, et al.
Cancers
|
August 7, 2021
Characteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma
Pierangela Sepe, Arianna Ottini, Chiara Carlotta Pircher, et al.
Pharmacogenomics and Personalized Medicine
|
April 10, 2014
Targeted treatments in advanced renal cell carcinoma: focus on axitinib
Elena Verzoni, Paolo Grassi, Isabella Testa, et al.
Clinical Genitourinary Cancer
|
October 11, 2025
Bone Health and Body Composition as Predictive and Prognostic Markers in Metastatic Castration-resistant Prostate Cancer: A Meet-URO Narrative Review
Anna Amela Valsecchi, Maria Concetta Cursano, Francesco Pantano, et al.
Future Oncology (London, England)
|
July 25, 2019
Role and relevance of quality indicators in the selection of first-line treatment of patients with metastatic renal cell carcinoma: a position paper of the MeetURO Group
Giuseppe Procopio, Sandro Pignata, Amelia Altavilla, et al.
Page
of 29
Search research articles
Search
Showing results (61-70 of 289) with videos related to
Sort By:
Page
of 29
Expert Review of Anticancer Therapy
|
December 15, 2015
Treatment of elderly patients with metastatic renal cell carcinoma
Elisa Zanardi, Paolo Grassi, Alessia Cavo, et al.
Therapeutic Advances in Urology
|
July 11, 2015
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma
Elisa Zanardi, Elena Verzoni, Paolo Grassi, et al.
American Journal of Clinical Oncology
|
September 26, 2013
Safety of Abiraterone Acetate in Castration-resistant Prostate Cancer Patients With Concomitant Cardiovascular Risk Factors
Giuseppe Procopio, Paolo Grassi, Isabella Testa, et al.
Clinical Genitourinary Cancer
|
August 28, 2014
Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data
Roberto Iacovelli, Matteo Santoni, Elena Verzoni, et al.
Cancer Biology & Therapy
|
July 25, 2012
Medical strategies for treatment of castration resistant prostate cancer (CRPC) docetaxel resistant
Amelia Altavilla, Roberto Iacovelli, Giuseppe Procopio, et al.
Tumori
|
August 8, 2007
Merkel cell carcinoma after liver transplantation: a case report
Emilio Bajetta, Marco Platania, Laura Catena, et al.
Cancers
|
August 7, 2021
Characteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma
Pierangela Sepe, Arianna Ottini, Chiara Carlotta Pircher, et al.
Pharmacogenomics and Personalized Medicine
|
April 10, 2014
Targeted treatments in advanced renal cell carcinoma: focus on axitinib
Elena Verzoni, Paolo Grassi, Isabella Testa, et al.
Clinical Genitourinary Cancer
|
October 11, 2025
Bone Health and Body Composition as Predictive and Prognostic Markers in Metastatic Castration-resistant Prostate Cancer: A Meet-URO Narrative Review
Anna Amela Valsecchi, Maria Concetta Cursano, Francesco Pantano, et al.
Future Oncology (London, England)
|
July 25, 2019
Role and relevance of quality indicators in the selection of first-line treatment of patients with metastatic renal cell carcinoma: a position paper of the MeetURO Group
Giuseppe Procopio, Sandro Pignata, Amelia Altavilla, et al.
Page
of 29